International Psychometric Validation Study of the Intestinal Gas Questionnaire (IGQ)
NCT03002584 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2019-02-18
Summary
Objective: To confirm the psychometrics properties of the Intestinal Gas Questionnaire (IGQ) in subjects with Irritable Bowel Syndrome (IBS) diagnosis and General population both complaining of Gas-Related Symptoms (GRS).
IGQ has been developed previously simultaneously in UK English, French and Spanish through qualitative research with subject interviews. The conceptual framework of the IGQ assesses both GRS and their impact on daily life. Similar concepts were identified for both subjects with IBS diagnosis and general population and complaining of gas-related symptoms.
The IGQ consists of a 24-hour recall symptom diary assessing 7 gas-related symptoms (17 items) and a 7-day recall questionnaire which assesses the impact of those symptoms (26 items)
Conditions
- IBS - Irritable Bowel Syndrome
- General Population
Interventions
- OTHER
-
completion of self-reported questionnaires
Single completion: Participants will have to complete the IGQ, the generic health status EQ-5D questionnaire, the specific FDDQL questionnaire (Functional Digestive Disorders Quality of Life). Test-retest: during the second completion within a mean 7-day interval, participants will complete the IGQ and a single global Gastro-Intestinal Well-Being scale
Sponsors & Collaborators
-
EA 7334, Patient-Centered Outcomes Research
collaborator UNKNOWN -
University of Manchester
collaborator OTHER -
Hospital Vall d'Hebron
collaborator OTHER -
Hôpital Louis Mourier
collaborator OTHER -
University Paris 7 - Denis Diderot
lead OTHER
Principal Investigators
-
Olivier Chassany, MD, PhD · EA 7334, University Paris-Diderot, Paris
-
Peter Whorwell, MD, PhD · university of Manchester, Manchester
-
Fernando Azpiroz, MD, PhD · Hospital Vall d'Hebron, Barcelona
-
Benoit Coffin, MD, PhD · Hopital Louis Mourier, Colombes
-
Martin Duracinsky, MD, PhD · EA 7334, University Paris-Diderot, Paris
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-10
- Primary Completion
- 2018-04-30
- Completion
- 2018-07-10
Countries
- France
- Spain
- United Kingdom
Study Locations
More Related Trials
-
i-CBT Functional Gastrointestinal Disorders in Youth: the Impact of Negative Illness Understanding and Parental Illness Worries
NCT05486585 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Irritable Bowel Syndrome Regional Cohort
NCT06900491 ·Status: RECRUITING
-
Efficacy of Psychological Therapies in Patients With Functional Bowel Disorders
NCT04060121 ·Status: COMPLETED
-
Efficacy of Hydrogen Breath Test in the Patients With Irritable Bowel Syndrome
NCT02242175 ·Status: UNKNOWN ·Phase: NA
-
Online Low-FODMAP Diet in Irritable Bowel Syndrome
NCT07172581 ·Status: COMPLETED ·Phase: NA
-
Investigating the Gut Microbiome and Symptomology in IBS
NCT06708533 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Practice Change for Patients With Severe Chronic, Clinically Unexplained Gastrointestinal Symptoms
NCT05274854 ·Status: RECRUITING ·Phase: NA
-
Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome
NCT00738920 ·Status: COMPLETED ·Phase: NA
-
Assessing Associations Between IBS Symptoms, Nutrition and QoL in IBS Patients Using a Questionnaire
NCT03824821 ·Status: COMPLETED
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2
-
Intestinal Microbiome and Psychological Correlates in Irritable Bowel Syndrome and Inflammatory Bowel Disease
NCT02536131 ·Status: COMPLETED ·Phase: NA
-
Patient Attributes for Optimal Treatment Outcome in Irritable Bowel Syndrome.
NCT01297556 ·Status: UNKNOWN ·Phase: NA
-
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
NCT03687814 ·Status: RECRUITING ·Phase: NA
-
Low FODMAP Diet in Patients With IBS
NCT05618106 ·Status: COMPLETED ·Phase: NA
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Efficacy of the DOMINO Diet App in IBS
NCT05808036 ·Status: RECRUITING ·Phase: NA
-
Internet-delivered Cognitive Behavior Therapy for Adolescents With Functional Gastrointestinal Disorders: a Pilot Study
NCT02033161 ·Status: COMPLETED ·Phase: NA
-
Diets in Symptom Relief and the Influence of Quality of Life in People With Irritable Bowel Syndrome
NCT02450370 ·Status: COMPLETED ·Phase: NA
-
Culturally Adapted Psychological Intervention for the Management of Irritable Bowel Syndrome (IBS)
NCT03379064 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)
NCT04072991 ·Status: COMPLETED ·Phase: NA
-
Emotion Focused Therapy in Irritable Bowel Syndrome Patients
NCT02657668 ·Status: COMPLETED ·Phase: NA
-
IQP-CL-101 in IBS Management
NCT01774825 ·Status: COMPLETED ·Phase: PHASE3
-
Fecal Microbiota Transplantation in Irritable Bowel Syndrome With Bloating
NCT02299973 ·Status: COMPLETED ·Phase: NA
-
Brain-Gut-Microbiota Interaction in IBS
NCT04296552 ·Status: UNKNOWN ·Phase: NA
-
Sex Differences in Effectiveness of CBT on IBS Project 3
NCT05155631 ·Status: COMPLETED ·Phase: NA